Tryptamine Therapeutics Limited (ASX:TYP)
Australia · Delayed Price · Currency is AUD 0.0350
+0.0010 (2.94%)
At close: Aug 14, 2025, 4:00 PM AEST
Tryptamine Therapeutics Market Cap
Tryptamine Therapeutics has a market cap or net worth of 50.38 million as of August 14, 2025. Its market cap has increased by 110.66% in one year.
Market Cap
50.38M
Enterprise Value
47.56M
Revenue
1.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since May 29, 2024, Tryptamine Therapeutics's market cap has increased from 38.06M to 50.38M, an increase of 32.37%. That is a compound annual growth rate of 26.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 48.94M | 0.91% |
| Dec 31, 2024 | 48.50M | 27.43% |
| May 29, 2024 | 38.06M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 127.98B |
| Pro Medicus | 31.67B |
| Cochlear | 20.40B |
| Sonic Healthcare | 13.83B |
| Ramsay Health Care | 8.87B |
| Telix Pharmaceuticals | 5.64B |
| Ansell | 4.51B |
| Mesoblast | 2.93B |